Services
Press
Contact
English
- Deutsch (German)
- 日本語 (Japanese)

Search for:

info@vasro.net
+49 (0)69 90 28 39 81

Call us Mon - Fri: 8:30 AM - 6:00 PM

Services
Press
Contact
English
- Deutsch (German)
- 日本語 (Japanese)

Commodity

VASRO GmbH > Press > Commodity

It seems we can’t find what you’re looking for. Perhaps searching can help.

Search for:

Search

Search for:

Categories

Energy
Equity Analysis reports
Equity Research Coverage
Market Intelligence
Pharma & Biotech
Tech
Unkategorisiert

Recent Posts

Ainos, Inc.: Three Patents Approved in Japan, and a Dataset Gathering Pace September 11, 2026

Baladna: The Capital Is Raised, Algeria Is Building – VASRO Reiterates BUY at QAR 2.33 September 7, 2026

Sirnaomics Ltd.: Every Approved siRNA Drug Works in the Liver. This One Was Injected Into Skin Cancer. VASRO Initiates Coverage With BUY September 7, 2026

Zaptec ASA: Europe’s Largest AC Charging Brand, With the Service Layer Priced at Zero – VASRO Initiates Coverage With BUY August 31, 2026

Spinneys 1961 Holding PLC: The Estate Grew 17%, Demand Did Not — First Half 2026 Update August 12, 2026

VASRO GmbH specializes in equity analysis, market intelligence, and investment strategy for the pharmaceutical, biotechnology, and IT sectors. We deliver tailored insights to drive informed investment decisions and achieve exceptional results.

Contact Info

Am Hauptbahnhof 16, 60329 Frankfurt am Main, Germany
+49 (0)69 90 28 39 81
Info@vasro.net
8:30 AM - 6:00 PM

Navigation

Imprint
Privacy Policy
Change privacy settings
Application
About
FAQ

©copyright 2025 VASRO GmbH.